Management of Subacute Thyroiditis – A Systematic Review of Current Treatment Protocols
Ishita Ray,Brandon D’Souza,Pallab Sarker,Pawan Agarwal
DOI: https://doi.org/10.2147/IJGM.S366784
IF: 2.145
2022-08-07
International Journal of General Medicine
Abstract:Ishita Ray, 1 Brandon D'Souza, 2 Pallab Sarker, 3 Pawan Agarwal 4 1 Department of Medicine, Mahatma Gandhi Memorial Medical College, Indore, India; 2 Department of Medicine, Dr. D.Y. Patil Medical College, Pimpri-Chinchwad, India; 3 Department of Medicine, Sher E Bangla Medical College, Barisal City, Bangladesh; 4 Department of Surgery, Netaji Subhash Chandra Bose Medical College Jabalpur, Jabalpur, India Correspondence: Ishita Ray, Madan Mahal Hospital, Prem Nagar, Nagpur Road, Jabalpur, Madhya Pradesh, 482001, India, Tel +918959393344, Email Purpose: This systematic review endeavors to find an effective treatment protocol for subacute thyroiditis (SAT) to minimize side effects, recurrence and long-term hypothyroidism. Materials and Methods: We analyzed available original studies on treatment protocols for SAT. A thorough literature search was performed on the following online databases PubMed, Cochrane library nd Google Scholar using appropriate keywords for choosing relevant articles. Two reviewers assessed the methodological quality of selected articles independently using a critical appraisal instrument. The results were analyzed and synthesized qualitatively using the level of evidence method. Results: The literature search retrieved a total of 460 publications after abstract screening; out of which 36 articles met the inclusion criteria. After full text screening, 23 articles were further excluded as they were focusing on aspects of SAT other than management, the remaining 15 articles were investigated for both reliability and validity. Thirteen studies provided low-quality evidence, and two randomized control trials (RCT) provided a high quality of evidence. Steroid therapy was found to be the most effective for moderate to severe SAT and provided relief from acute symptoms but was found to not be a risk factor for recurrence. Low initial doses of steroid (15 mg) were preferred over high initial dosage (30– 40 mg). Furthermore, a look into the mode of steroid delivery (RCT) revealed that intrathyroidal steroid therapy can potentially become a safer and faster mode of therapy. The duration of tapering was found to be of significance as a short tapering period was linked with greater recurrence rates. Conclusion: Low initial doses of steroid along with an extended tapering period may help lower recurrence rates; also, intrathyroidal steroid injections are potentially a better alternative to oral prednisone (PSN) with regard to safety and speed of action. However, the evidence is of moderate quality and further investigation is required. Keywords: subacute thyroiditis, de Quervain thyroiditis, painful thyroiditis, steroid, NSAIDS, recurrence Subacute thyroiditis (SAT) (also called de Quervain thyroiditis or granulomatous thyroiditis) is a self-limited, inflammatory thyroid disorder of a possible viral origin associated commonly with pain in the thyroid and various systemic symptoms. 1 SAT is a common cause of thyrotoxicosis and is the most common painful thyroid disease. Clinical signs associated with SAT include: a frequent history of recent viral illness; enlarged and firm thyroid gland; tenderness; thyrotoxicosis; referred pain to the parietal regions, occipital regions and the ears, jaw, or the throat; raised erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels; and decreased radioactive Iodine (I) uptake. SAT may also present with mild anemia, diffuse heterogeneous ultrasonography (USG) changes, and occasionally decreased color Doppler blood flow signals. 3 The recent pandemic involving the severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has shown to be a strong etiological factor in the development of subacute thyroiditis, with some studies showing close to 18.8% of all SAT cases were due to SARS-CoV2. 4 SARS-CoV2 induced SAT is generally found to have slightly higher severity with regards to clinical presentation and lab findings compared to non-SARS-Cov2 patients with SAT in predisposed individuals. 5 No definitive curative treatment for SAT exists, but there are effective treatments that will ameliorate symptoms and allow the disease to run its course as an asymptomatic condition. Corticosteroids have proved to be extremely valuable in the treatment of most SAT patients. They have a rapid clinical response, with many cases reporting total relief of symptoms within 24 hours. However, the most effective treatment protocol for SAT is not well defined. In this systematic review we have gone through all the relevant original articles on the management of SAT published between January 2000 and May 2022 in order to determine the most effective treatment protocol for SAT -Abstract Truncated-
medicine, general & internal